Back to search

Boston University

The intersection of a clinical trial participation and HPV vaccine intent: a study of women aged 16-45

Abstract

dc:description.abstract

BACKGROUND: HPV (Human Papillomavirus) is the most common sexually transmitted infection in the United States, with about 13 million new infections annually. 90% of cervical cancer cases are attributed to HPV diagnosis. In addition, HPV can also lead to five other types of cancer, including oropharyngeal, anal, vaginal, vulvar, and penile cancers. Human papillomavirus (HPV) vaccination is a critical tool for cancer prevention, yet vaccine uptake remains suboptimal, particularly among underserved and diverse populations. This thesis investigates the demographic, socioeconomic, health, and lifestyle factors influencing HPV vaccine intent among women participating in a parent HPV vaccine clinical trial entitled “An Open-Label Clinical Trial Evaluating the Immunogenicity of the 9vHPV Vaccination Regimen over 6 months Among Women Aged 16 to 45 years old, An Exploratory Immunogenicity Study." METHODS: This cross-sectional sub-analysis was conducted within the context of a larger open-label clinical trial. The parent trial focused on evaluating the immunogenic response to the 9-valent HPV vaccine, while the present study examined behavioral and sociodemographic factors influencing vaccine intent among enrolled participants. Survey data were collected from 330 participants enrolled in the parent study. The research was carried out in a safety-net hospital setting, which primarily serves medically underserved and socioeconomically diverse populations. Participants completed a structured survey assessing demographic characteristics, health and socioeconomic status, lifestyle behaviors, and medical history. Descriptive statistics summarized population characteristics, and logistic regression analyses were employed to examine associations between independent variables (e.g., age, perceived stigma) and HPV vaccine offer and intent. RESULTS: The majority of participants were aged 27–45 years (64.65%), female (96.36%), and born outside the USA (60.61%). The sample was racially and ethnically diverse, with African American (24.21%), Asian (21.33%), and Hispanic (18.16%) individuals comprising significant subgroups. Nearly three-quarters (74.40%) of participants received health information from providers, while only 12.80% relied on the internet. Most participants had health insurance (95.96%) and high levels of education (66.87% held a college degree). Intent to vaccinate was positively influenced by healthcare provider recommendations; 72% reported they would accept the vaccine if offered during a child’s primary care visit, and 68% of parents cited provider endorsement as a key influence. However, barriers remained: 35% lacked sufficient vaccine knowledge, 28% feared side effects, and 22% doubted the vaccine’s effectiveness. Notably, 32% had never discussed the HPV vaccine with a provider, revealing missed opportunities for intervention. Logistic regression analyses indicated that neither age nor perceived stigma were statistically significant predictors of being offered the vaccine. Vaccine offer rates were consistently high across all groups (~80%). Health behaviors such as smoking (12.95% current smokers) and limited physical activity (41.21% exercising less than three times per week) were common, as were elevated stress levels (59.24%). CONCLUSIONS: This study highlights the complex interplay of demographic, behavioral, and systemic factors influencing HPV vaccine decision-making. While provider recommendation is a major facilitator, substantial informational and structural barriers persist. The findings underscore the importance of culturally responsive, provider-driven communication strategies—particularly in safety-net settings serving diverse, immigrant populations. Tailored public health interventions addressing stigma, knowledge gaps, and lifestyle-related barriers are essential to improve HPV vaccine uptake and equity.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pekar, Isabella
Advisor dc:contributor.advisor
  • Pierre-Joseph, Natalie

Subjects

dc:subject × 9

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52347

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Pekar, Isabella. The intersection of a clinical trial participation and HPV vaccine intent: a study of women aged 16-45. masters thesis, Boston University, 2025. https://hdl.handle.net/2144/52347